Chronic buspirone treatment differentially regulates 5-HT1A and 5-HT2A receptor mRNA and binding sites in various regions of the rat hippocampus
- 30 September 1995
- journal article
- research article
- Published by Elsevier in Molecular Brain Research
- Vol. 32 (2) , 348-353
- https://doi.org/10.1016/0169-328x(95)00098-d
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sitesNature, 1994
- Ontogeny of GABAA receptor subunit mRNAs in rat spinal cord and dorsal root gangliaJournal of Comparative Neurology, 1993
- Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigmLife Sciences, 1991
- Brain 5-HT1 binding sites in depressed suicidesPsychopharmacology, 1990
- Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997Neuropharmacology, 1990
- Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortexBrain Research, 1988
- Reversal of helpless behavior in rats by putative 5-HT1A agonistsBiological Psychiatry, 1988
- Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in ratsBrain Research, 1985
- Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brainBrain Research, 1984